(LYSX) Multi Units France - Euro - Overview
Etf: ETF, Eurozone, Blue-Chip, Currency-Hedge, Equity
| Risk 5d forecast | |
|---|---|
| Volatility | 13.2% |
| Relative Tail Risk | 2.30% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.68 |
| Alpha | 9.29 |
| Character TTM | |
|---|---|
| Beta | 0.216 |
| Beta Downside | 0.300 |
| Drawdowns 3y | |
|---|---|
| Max DD | 16.49% |
| CAGR/Max DD | 0.94 |
Description: LYSX Multi Units France - Euro January 11, 2026
The Lyxor EURO STOXX 50 (DR) UCITS ETF (ticker LYSX) is a Germany-domiciled, UCITS-compliant fund that seeks to replicate the performance of the EURO STOXX 50 Net Return EUR index. It uses a daily USD-hedge built into the share class to neutralise currency risk between the euro and the US dollar, offering investors exposure to 50 blue-chip Eurozone stocks while maintaining a dollar-neutral return profile.
As of the latest data (Q4 2025), the fund carries an expense ratio of roughly 0.15% and manages about €2 billion in assets, with a tracking error against the underlying index of < 0.3% over the past 12 months. The top five constituents-ASML, LVMH, SAP, Siemens and TotalEnergies-account for roughly 25% of the portfolio, and sector weights are dominated by Industrials (≈30%), Financials (≈20%) and Consumer Discretionary (≈15%). Key macro drivers include ECB monetary-policy stance, Eurozone GDP growth (forecast ≈1.3% YoY for 2026), and energy price trends, which together influence earnings outlooks for the index’s heavy industrial and energy exposure.
For a deeper dive into the fund’s risk-adjusted performance and how it fits within a diversified Eurozone equity allocation, you might explore the ValueRay platform for additional analytics.
What is the price of LYSX shares?
Over the past week, the price has changed by +0.87%, over one month by +1.25%, over three months by +7.44% and over the past year by +15.24%.
Is LYSX a buy, sell or hold?
What are the forecasts/targets for the LYSX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 76.4 | 14% |
LYSX Fundamental Data Overview February 03, 2026
Revenue TTM = 0.0 EUR
EBIT TTM = 0.0 EUR
EBITDA TTM = 0.0 EUR
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 3.90b EUR (3.90b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 3.90b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 3.90b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 25.0% (EU avg default 25%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 25.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 6.71% (E(3.90b)/V(3.90b) * Re(6.71%) + (debt-free company))
Discount Rate = 6.71% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Fair Price DCF = unknown (Cash Flow 0.0)